Dr. Neil Adrian Zakai MD
Hematologist-Oncologist | Hematology & Oncology
Given Building E214 Univer Burlington VT, 05405About
Dr. Neil Zakai is a hematologist oncologist practicing in Burlington, VT. Dr. Zakai specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology- 2007
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score.
- ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
- Activated partial thromboplastin time and risk of future venous thromboembolism.
- Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study.
- Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
- Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
- Racial differences in venous thromboembolism.
- Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.
- Why is my patient anemic?
- Persistence and remission of musculoskeletal pain in community-dwelling older adults: results from the cardiovascular health study.
- Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association.
- Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: Reasons for Geographic and Racial Differences in Stroke study 2003-2007.
- N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.
- Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.
- ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort.
Treatments
- Bone Marrow Biopsy
Fellowships
- Brown University School of Medicine - Hematology/Oncology
Dr. Neil Adrian Zakai MD's Practice location
Dr. Neil Adrian Zakai MD's reviews
Write ReviewPatient Experience with Dr. Zakai
Recommended Articles
- How to Show Social Support for Lymphoma
A cancer diagnosis can shake an individual’s world, and not just the physical aspects of their world, but all corners of it. Although cancer attacks the body, it necessarily also affects a person’s mental and emotional state, and it can have an impact on other people close to the affected...
- Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause
Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...
- John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society
Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...
- Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey
While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Life Lessons After Multiple Misdiagnoses of Lymphoma
28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...
Nearby Providers
- Dr. Chris E Holmes MD111 Colchester Ave Burlington VT 05401
- Dr. Steven Ades MD111 Colchester Ave Burlington VT 05401
- Dr. Natalie Sinclair Other111 Colchester Ave Burlington VT 05401
- Dr. Steven P Emmons MDUvm Hematology Oncology Burlington VT 05405
- Dr. Christian Anton Thomas MD792 College Pkwy Colchester VT 05446
- Dr. Susan Radoux M.D.111 Colchester Ave Burlington VT 05401